Narrative review of palmitoleic acid links to metabolic health and fatty liver outcomes
Palmitoleic Acid Shows Mixed Links to Metabolic Health
This narrative review examines palmitoleic acid (POA) supplementation and food matrices regarding insulin resistance, fatty liver, and hyper…
Higher palmitoleic acid levels are tied to fatty liver and insulin resistance, but supplements show neutral effects.
Bayesian network meta-analysis of drugs for pediatric NAFLD steatosis improvement
New analysis shows specific drugs help children with fatty liver disease improve liver health and lower body weight
This Bayesian network meta-analysis evaluated drugs in pediatric NAFLD patients confirmed by ultrasound or biopsy. The review synthesized da…
A large review of 1,582 children found that certain medicines helped reduce liver fat and improve blood markers. Energy-focused drugs were b…
Pediatric Gut Microbiome Links to Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes
Your Child's Gut Health May Protect Against Fatty Liver Disease
Current literature reveals complex associations between the pediatric gut microbiome and metabolic dysfunction-associated steatotic liver di…
• Specific gut bacteria patterns predict fatty liver risk in children • Helps parents of overweight kids with diabetes or obesity • Not read…
Meta-analysis finds no significant difference in Lp(a) levels in MASLD patients vs controls
Popular Heart Risk Marker Fails to Predict Fatty Liver Disease
This meta-analysis of observational studies compared circulating lipoprotein(a) concentrations between adults with MASLD/NAFLD/MAFLD and con…
A common blood test for heart disease risk shows no link to fatty liver disease, disappointing hopes for a simple diagnostic tool.
Meta-analysis shows curcumin reduces weight but lacks impact on BMI or waist circumference in metabolic fatty liver disease patients
Curcumin Helps Weight But Not Waist Size In Fatty Liver
A meta-analysis of curcumin supplementation in patients with metabolic-associated fatty liver disease revealed a significant reduction in bo…
Curcumin might help you lose a few pounds but it will not shrink your waist or fix your BMI score
Narrative review links ultra-processed food to obesity and multiple metabolic conditions
Is Ultra-Processed Food Driving Obesity And Infertility
This narrative review examines the association between ultra-processed food (UPF) consumption and adverse health outcomes.
Ultra-processed foods might hurt your health by causing weight gain or by acting directly on your body without weight gain at all.
Elevated free and bioavailable testosterone linked to non-alcoholic fatty liver disease risk in postmenopausal women
High Free Testosterone Levels May Worsen Liver Disease In Older Women
This prospective cohort study examined 1,705 postmenopausal women over 5,269 person-years.
High levels of free testosterone in older women may signal a higher risk of developing or worsening fatty liver disease.
Review of scRNA-seq applications in non-alcoholic fatty liver disease and hepatocellular carcinoma research
New sequencing tools map liver disease across many species
This narrative review examines the use of single-cell and single-nucleus RNA sequencing in models of non-alcoholic fatty liver disease, fibr…
Scientists used advanced sequencing to study liver disease in humans and animals. This review maps how the disease changes at a cellular lev…
Ketotifen shows significant improvements in hepatic steatosis and fibrosis indices compared with vitamin E in a pilot study of NAFLD
Ketotifen beats Vitamin E for fatty liver disease in new trial
This randomized pilot study enrolled 60 individuals with non-alcoholic fatty liver disease (NAFLD) and followed them for 6.0 months.
New research shows a common allergy medicine reduces liver fat and scarring more effectively than Vitamin E for people with fatty liver dise…
Meta-analysis shows salidroside improves metabolic markers in rodent NAFLD models
New Natural Compound Could Lower Liver Fat in Early Tests
This meta-analysis synthesizes data from 12 eligible animal studies investigating salidroside in rodent NAFLD models.
A review of animal studies suggests a specific compound may help heal fatty livers.
Narrative review links microgravity exposure to altered fat distribution and inflammation in metabolic disease models
How Space Travel Is Unlocking New Ways to Fight Obesity and Diabetes
This narrative review synthesizes evidence from human studies, animal models, and in vitro experiments regarding microgravity and metabolic …
This research shows that the same health problems astronauts face in space are happening to people on Earth who sit too much, and it may lea…
Narrative Review Suggests Electroacupuncture May Benefit NAFLD with Minimal Side Effects
Electroacupuncture shows promise for non-alcoholic fatty liver disease
This narrative review summarizes evidence on electroacupuncture for non-alcoholic fatty liver disease (NAFLD).
A review suggests electroacupuncture may help treat non-alcoholic fatty liver disease with minimal side effects, offering a new option for p…
Research across Metabolic Dysfunction-Associated Steatotic Liver Disease
Related studies from across the Metabolic Dysfunction-Associated Steatotic Liver Disease family.
Dioscin shows therapeutic potential for various liver disorders including MASLD and hepatocellular carcinoma
Plant Compound Dioscin Shows Promise For Liver Disease
This systematic review evaluates the hepatoprotective effects and pharmacokinetics of Dioscin in various liver diseases. The review conclude…
A plant compound called Dioscin may help protect the liver, but human evidence is still missing and high doses carry risks.
MASLD linked to 35% higher odds of HFpEF in pooled analysis of 899,629 patients
Liver Disease Linked to Higher Risk of Heart Failure
This meta-analysis of 3 studies (899,629 patients, 47,610 with MASLD) found that MASLD was associated with higher odds of clinically diagnos…
People with metabolic dysfunction-associated steatotic liver disease (MASLD) show a higher risk of developing heart failure with preserved e…
Ketogenic diets and intermittent fasting may improve weight, insulin sensitivity, and hepatic steatosis in MASLD
Ketogenic diets and fasting may improve liver health in patients
This narrative review examines the impact of ketogenic dietary interventions and intermittent fasting on patients with metabolic dysfunction…
New research suggests that ketogenic diets and intermittent fasting can help manage weight and liver fat in people with metabolic liver dise…
Viral hepatitis infections pose significantly higher risk for liver cancer than smoking-related lung cancer
Comparing the risks of liver cancer from hepatitis versus lung cancer from smoking
This meta-analysis of 86,097,714 participants analyzed the relative risks of liver cancer from various exposures compared to lung cancer fro…
New data shows that certain hepatitis viruses pose a much higher risk for liver cancer than smoking does for lung cancer.
Efficacy of High-Intensity Interval Training and Moderate-Intensity Continuous Training in MASLD
Exercise Types Improve Liver Health in MASLD Patients
Meta-analysis confirms that both HIIT and MICT significantly improve body composition, cardiometabolic markers, and liver function in MASLD …
High-intensity interval training and moderate continuous exercise both help MASLD patients. They improve body composition, metabolism, and l…
rs2896019 G allele associated with 51% increased risk of MASLD susceptibility
Genetic variant linked to increased risk of fatty liver disease
This meta-analysis of 15028 adults identified the rs2896019 polymorphism (G allele) as a significant risk factor for MASLD. The study found …
A specific genetic marker may significantly increase the risk of developing and progressing to severe fatty liver disease.
Telmisartan leads to modest fasting blood sugar reduction in patients with MASLD
Telmisartan Shows Modest Effects on Blood Sugar in Liver Disease
This meta-analysis of 258 adults with MASLD found that telmisartan resulted in a modest reduction in fasting blood sugar of -2.78 mg/dL. Oth…
A review of clinical data suggests that the medication telmisartan may lower fasting blood sugar in adults with certain types of liver disea…
Clinical trials for MASLD show limited racial and ethnic diversity despite increasing Hispanic enrollment
Clinical trials for fatty liver disease lack diversity
This meta-analysis of 91 randomized controlled trials evaluates racial and ethnic diversity in MASLD clinical trials. While Hispanic enrollm…
Most fatty liver disease trials underreport ethnicity, and Black patients are only 2.5% of participants, despite the disease's impact.
Fibrosis-informed markers provide a decision architecture for statin allocation in intermediate-risk MASLD patients
New guidelines help doctors choose statins for liver disease patients
This guideline proposes a decision-making framework for statin therapy in the intermediate-risk stratum for patients with MASLD. It utilizes…
Doctors now have a clearer way to decide who needs statin treatment when liver health and heart risk overlap.
Fatty pancreas prevalence 30.5% and linked to higher pancreatitis, cancer risk
Fatty pancreas is linked to higher risk of pancreatic cancer
This meta-analysis of 124 studies including 141,416 healthy or routine-examination participants found a fatty pancreas prevalence of 30.5%, …
A fatty pancreas is common and linked to a higher risk of serious conditions like pancreatic cancer and diabetes.
AI, machine learning, and deep learning models facilitate multimodal diagnosis and prognosis in MASLD
Artificial intelligence helps identify and predict fatty liver disease
This scoping review synthesizes 73 studies regarding the role of AI, machine learning, and deep learning in diagnosing and predicting outcom…
New technology is helping doctors identify fatty liver disease and predict its progress by analyzing complex data and medical images.
Phytochemicals modulate miRNA-mediated regulatory networks to influence metabolic reprogramming and cancer-associated signaling
Phytochemicals May Influence RNA Networks Linked to Chronic Diseases
This narrative review explores how phytochemicals interact with miRNA-mediated regulatory networks through transcriptional, epigenetic, and …
New research explores how plant-based compounds might influence genetic switches that play a role in cancer and metabolic disorders.
Questions about Non-Alcoholic Fatty Liver Disease
Do quercetin and apigenin show promise for treating non-alcoholic fatty liver disease?
Yes, quercetin and apigenin show promise for NAFLD by reducing liver fat and inflammation, but most evidence comes from lab and animal studies; human trials are limited.
Full answer →How does exercise training improve metabolic markers for nonalcoholic fatty liver disease?
Exercise training reduces liver fat, lowers blood sugar and insulin, and improves mitochondrial function in people with nonalcoholic fatty liver disease.
Full answer →Does exercise training help reduce liver fat in people with nonalcoholic fatty liver disease?
Yes, exercise training reduces liver fat in people with NAFLD, with high-intensity interval training and aerobic exercise showing the strongest effects.
Full answer →What are the current management options for nonalcoholic fatty liver disease?
Current management for nonalcoholic fatty liver disease focuses on lifestyle changes like weight loss and exercise, while new drug options are being studied but none are yet approved in the United States.
Full answer →Does eating ultra-processed food make my nonalcoholic fatty liver disease worse?
Eating ultra-processed foods is linked to obesity and metabolic disease, which are major drivers of nonalcoholic fatty liver disease (NAFLD).
Full answer →What are the management options for NAFLD and NASH without trial data?
Lifestyle changes (diet, exercise, weight loss) are the mainstay of NAFLD/NASH management; vitamin E and some medications may help, but always consult your doctor.
Full answer →Which other digestive conditions are linked to Non-Alcoholic Fatty Liver Disease in recent reviews?
Recent reviews link NAFLD to periodontitis, type 2 diabetes, obesity, cardiovascular disease, and bile acid-related conditions like IBS-D and CRC.
Full answer →Does ketotifen work better than vitamin E for treating Non-Alcoholic Fatty Liver Disease?
A pilot study suggests ketotifen may improve liver fat and fibrosis more than vitamin E in NAFLD, but more research is needed.
Full answer →